
Sign up to save your podcasts
Or


Dr Fontanarosa provides summary and commentary on the April 18, 2012 issue of JAMA, the Journal of the American Medical Association. Bevacizumab and Non–Small Cell Lung Cancer Survival, Helicopter vs Ground EMS and Trauma Survival, Radiation Therapy Choices and Prostate Cancer Morbidity, Survival After Open vs Endovascular Repair of AAA, Survival After Partial vs Radical Nephrectomy, Setting PCORI's priorities, Changes to research regulations.
By JAMA Network3.9
126126 ratings
Dr Fontanarosa provides summary and commentary on the April 18, 2012 issue of JAMA, the Journal of the American Medical Association. Bevacizumab and Non–Small Cell Lung Cancer Survival, Helicopter vs Ground EMS and Trauma Survival, Radiation Therapy Choices and Prostate Cancer Morbidity, Survival After Open vs Endovascular Repair of AAA, Survival After Partial vs Radical Nephrectomy, Setting PCORI's priorities, Changes to research regulations.

319 Listeners

698 Listeners

496 Listeners

168 Listeners

885 Listeners

295 Listeners

3,345 Listeners

1,148 Listeners

193 Listeners

92 Listeners

513 Listeners

369 Listeners

247 Listeners

424 Listeners

373 Listeners